Picture of Mesa Laboratories logo

MLAB — Mesa Laboratories News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Mesa Laboratories Inc reports results for the quarter ended in December - Earnings Summary

* Mesa Laboratories Inc  MLAB.OQ  reported quarterly
adjusted
earnings of 39 cents​​ per share for the quarter ended in
December, higher than the same quarter last year, when the
company reported EPS of 8 cents.  The mean expectation of
two analysts for the quarter was for earnings of 19 cents per
share. 
    * Revenue fell 1.5% to $53.47 million from a year ago;
analysts
expected $54.89 million. 
    * Mesa Laboratories Inc's reported EPS for the quarter was
39
cents​.
    * The company reported quarterly net income of $2.12
million.
    * Mesa Laboratories Inc shares had fallen by 10.3% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 25.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Mesa Laboratories
Inc is $115.00 
This summary was machine generated from LSEG data February 5 at
02:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      0.19           0.39           Beat
 Sep. 30 2023      0.16           -0.23          Missed
 Jun. 30 2023      -0.02          -0.10          Missed
 Mar. 31 2023      0.37           0.11           Missed

Recent news on Mesa Laboratories

See all news